Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Alopecia areata patients show increased inflammation and OX40 activation, suggesting a new treatment target.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

People who get alopecia areata after age 50 usually have mild symptoms, high chances of hair regrowth, and often have other health conditions.

A child with rough nails also had hair loss and allergies.

The document concludes that specific dermoscopic features can help diagnose different facial red skin conditions.

No strong genetic link to other skin conditions was found, but some genetic factors may make people more likely to get seborrheic dermatitis.

Baricitinib is widely used for several conditions, especially COVID-19, but its safety and effectiveness are still being evaluated.

Daily use of emollients from birth may reduce atopic dermatitis in infants, but results are mixed.

Stress can worsen skin diseases by affecting immune cells, hormones, and neurotransmitters in the skin.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

Nanotechnology could improve treatment for scars and atopic dermatitis by targeting skin issues more effectively.

Low-level light therapy safely improves hair coverage, thickness, and count in androgenetic alopecia patients.

Aging makes hair thinner and rougher, with less clear edges.

Hair from people with seborrheic dermatitis is thicker scaled, more damaged, and thinner than healthy hair, and atomic force microscopy can help monitor the condition.

The study created a numerical system to describe and compare 601 jobs in Japan.

Cats with atopic dermatitis often have severe, year-round itching and respond well to certain treatments.

People with atopic dermatitis have a higher risk of developing autoimmune diseases.

Atopic dermatitis significantly lowers the quality of life for infants and their families.

Topical JAK inhibitors may help treat some skin conditions but need more research.

Removing Ctip2 in skin cells causes skin inflammation similar to atopic dermatitis.

Tralokinumab for atopic dermatitis may cause side effects like dizziness, headache, nausea, hair loss, and acne.

Many Korean patients with hair loss, skin allergies, and psoriasis use alternative medicine, but satisfaction is low.

Botanicals like green tea extract show potential for hair growth, but more research is needed.

People with atopic dermatitis are more likely to develop other skin conditions due to shared genetics and immune pathways.

Dupilumab may help hair regrowth in some patients with severe atopic dermatitis, but results vary.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

A cream with a specific hormone blocker increases hair growth in mice.